Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Organon & Co.
  6. Summary
    OGN   US68622V1061

ORGANON & CO.

(OGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
33.83(c) 33.42(c) 33.72(c) 33.76(c) 34.03(c) Last
1 950 103 1 570 318 1 953 210 1 280 625 4 337 979 Volume
-0.15% -1.21% +0.90% +0.12% +0.80% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 6 277 M - -
Net income 2021 1 493 M - -
Net Debt 2021 8 387 M - -
P/E ratio 2021 5,82x
Yield 2021 1,64%
Sales 2022 6 350 M - -
Net income 2022 1 431 M - -
Net Debt 2022 7 612 M - -
P/E ratio 2022 4,43x
Yield 2022 3,73%
Capitalization 8 628 M 8 628 M -
EV / Sales 2021 2,71x
EV / Sales 2022 2,56x
Nbr of Employees -
Free-Float 100,0%
More Financials
Company
Organon & Co. is a science-based global pharmaceutical company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. Its women's health portfolio includes Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. Its operating segments include the Organon Products... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about ORGANON & CO.
09/01ORGANON : BofA Securities Starts Organon & Co. at Buy with $43 Price Target
MT
09/01ORGANON : To Present at Morgan Stanley's 19th Annual Global Healthcare Virtual C..
BU
09/01ORGANON : To Present at Citi's 16th Annual BioPharma Virtual Conference
BU
08/25Warren Buffett's latest shopping spree
08/18ORGANON : Citigroup Adjusts Organon's Price Target to $43 From $35, Reiterates B..
MT
08/17STREET COLOR : Berkshire Hathaway Takes New Position in Organon, Dumps Biogen, A..
MT
08/16ORGANON : Morgan Stanley Adjusts Organon & Co.'s Price Target to $35 from $33, K..
MT
08/16ORGANON : & CO. Management's Discussion and Analysis of Financial Condition and ..
AQ
08/12US Stocks at Fresh Record Highs Thursday as Initial Jobless Claims Drop for T..
MT
08/12Equities Mixed Midday After Initial Jobless Claims Drop While Producer Prices..
MT
08/12MIDDAY REPORT : US Stocks Mixed After Initial Jobless Claims Drop While Producer..
MT
08/12ORGANON : Q2 Posts Lower Q2 Adjusted Earnings, Beats Street; Revenue Improves - ..
MT
08/12Organon & Co. Provides Earnings Guidance for the Year 2021
CI
08/12ORGANON : reports results for the second quarter ended June 30, 2021 and announc..
PU
08/12ORGANON & CO. : Results of Operations and Financial Condition, Regulation FD Dis..
AQ
More news
News in other languages on ORGANON & CO.
08/24Les dernières emplettes de Warren Buffett
06/16ORGANON : completa la adquisición de Alydia Health, una empresa de dispositivos ..
06/16ORGANON : vollzieht Übernahme von Alydia Health, einem Medizintechnik-Unternehme..
06/16ORGANON : finalise l'acquisition d'Alydia Health, une société de dispositifs méd..
06/03ORGANON : premier jour de cotation dans le rouge à New York
More news
Analyst Recommendations on ORGANON & CO.
More recommendations
Chart ORGANON & CO.
Duration : Period :
Organon & Co. Technical Analysis Chart | OGN | US68622V1061 | MarketScreener
Technical analysis trends ORGANON & CO.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 34,03 $
Average target price 42,25 $
Spread / Average Target 24,2%
EPS Revisions
Managers and Directors
Kevin Ali Chief Executive Officer & Director
Matthew M. Walsh Chief Financial Officer
Carrie Smith Cox Chairman
Sandra Milligan Head-Research & Development
Rachel A. Stahler Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
ORGANON & CO.0.00%8 628
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604